Assessment of Drug Interactions Relevant to Pharmacodynamic Indirect Response Models
暂无分享,去创建一个
Wojciech Krzyzanski | William J. Jusko | Justin C. Earp | Justin Earp | W. Jusko | A. Chakraborty | W. Krzyzanski | M. Zamacona | Abhijit Chakraborty | Miren K. Zamacona
[1] E. Mutschler,et al. Diuretic Effectiveness of Hydrochlorothiazide and Furosemide Alone and in Combination in Chronic Renal Failure , 1995, Journal of cardiovascular pharmacology.
[2] Wojciech Krzyzanski,et al. Mathematical Formalism and Characteristics of Four Basic Models of Indirect Pharmacodynamic Responses for Drug Infusions , 2004, Journal of Pharmacokinetics and Biopharmaceutics.
[3] J. V. van Rossum,et al. Affinity, intrinsic activity and drug interactions. , 1957, Pharmacological reviews.
[4] Berenbaum Mc. What is synergy? , 1989, Pharmacological reviews.
[5] W. Jusko,et al. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays. , 1998, The Journal of pharmacology and experimental therapeutics.
[6] E. J. Ariëns,et al. A molecular basis for drug action * , 1964, The Journal of pharmacy and pharmacology.
[7] W. Greco,et al. The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.
[8] Meindert Danhof,et al. Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers , 1992, Clinical pharmacology and therapeutics.
[9] W. Jusko,et al. Characterization of four basic models of indirect pharmacodynamic responses , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[10] W. Ambrosius,et al. Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive Subjects , 2001, Hypertension.
[11] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[12] J G Bovill,et al. The Pharmacodynamic Interaction of Propofol and Alfentanil during Lower Abdominal Surgery in Women , 1995, Anesthesiology.
[13] W. Jusko,et al. Pharmacoimmunodynamic interactions of interleukin‐10 and prednisone in healthy volunteers , 1999, Clinical pharmacology and therapeutics.
[14] J. O'dell,et al. Therapeutic strategies for rheumatoid arthritis. , 2004, The New England journal of medicine.
[15] P K Gessner,et al. Isobolographic analysis of interactions: an update on applications and utility. , 1995, Toxicology.
[16] Varun Garg,et al. Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[17] E. J. Ariëns,et al. A molecular basis for drug action.: The interaction of one or more drugs with different receptors * , 1964, The Journal of pharmacy and pharmacology.
[18] William J Jusko,et al. Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation. , 2002, Journal of pharmaceutical sciences.
[19] W F Ebling,et al. Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies? , 1996, Journal of pharmaceutical sciences.
[20] W. Jusko,et al. Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone , 1999, Journal of Pharmacokinetics and Biopharmaceutics.
[21] M. Berenbaum. What is synergy? , 1989, Pharmacological reviews.